Skip to main content
TipRanks
Go Ultimate75% OFF

Hemab Therapeutics Holdings, Inc. (COAG) Stock Price & Analysis

16 Followers

COAG Stock Chart & Stats

$39.06$0.01(0.01%)
At close: 4:00 PM EST
$30$40$50Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
$37.58 - $40.61
52-Week Range
$23.00 - $55.42
Previous Close
$39.06
Volume
N/A
Average Volume (3M)
477.85K
Market Cap
$1.83B
Enterprise Value
$1.01B
Total Cash (Recent Filing)
$430.24M
Total Debt (Recent Filing)
$965.00K
Price to Earnings (P/E)
―
Beta
-2.08
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Hemab Therapeutics Holdings, Inc. News

COAG FAQ

What was Hemab Therapeutics Holdings, Inc.’s price range in the past 12 months?
Hemab Therapeutics Holdings, Inc. lowest stock price was $23.00 and its highest was $55.42 in the past 12 months.
What is Hemab Therapeutics Holdings, Inc.’s market cap?
Hemab Therapeutics Holdings, Inc.’s market cap is $1.83B.
When is Hemab Therapeutics Holdings, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Hemab Therapeutics Holdings, Inc.’s earnings last quarter?
Hemab Therapeutics Holdings, Inc. released its earnings results on Nov 10, 2026. The company reported -$0.58 earnings per share for the quarter, missing the consensus estimate of -$0.502 by -$0.078.
Is Hemab Therapeutics Holdings, Inc. overvalued?
According to Wall Street analysts Hemab Therapeutics Holdings, Inc.’s price is currently Undervalued.
Does Hemab Therapeutics Holdings, Inc. pay dividends?
Hemab Therapeutics Holdings, Inc. does not currently pay dividends.
What is Hemab Therapeutics Holdings, Inc.’s EPS estimate?
Hemab Therapeutics Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hemab Therapeutics Holdings, Inc. have?
Hemab Therapeutics Holdings, Inc. has 46,730,610 shares outstanding.
What happened to Hemab Therapeutics Holdings, Inc.’s price movement after its last earnings report?
Hemab Therapeutics Holdings, Inc. reported an EPS of -$0.58 in its last earnings report, missing expectations of -$0.502. Following the earnings report the stock price went down -9.437%.
Which hedge fund is a major shareholder of Hemab Therapeutics Holdings, Inc.?
Hedge funds hold Hemab Therapeutics Holdings, Inc. shares: the largest hedge-fund position in Hemab Therapeutics Holdings, Inc. is 72,418,432 shares.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology